Smital Shah
Director/Board Member at PLIANT THERAPEUTICS, INC.
Net worth: 18 757 $ as of 2024-03-30
Profile
Smital Shah is an Independent Director at Pliant Therapeutics, Inc. She previously served as an Independent Director at Graphite Bio, Inc. and as Treasurer at Gilead Sciences, Inc. from 2012 to 2014.
From 2018 to 2022, she held the position of Chief Financial & Business Officer at ProQR Therapeutics NV.
Ms. Shah holds an MBA from the University of California, Berkeley and the Haas School of Business.
She also has a graduate degree from Virginia Polytechnic Institute & State University and an undergraduate degree from the University of Mumbai.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.00% | 2023-07-18 | 840 ( 0.00% ) | 18 757 $ | 2024-03-30 |
| 2023-06-06 | 0 ( -.--% ) | - $ | 2024-03-30 |
Smital Shah active positions
| Companies | Position | Start |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 2019-03-13 |
Former positions of Smital Shah
| Companies | Position | End |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director of Finance/CFO | 2022-09-30 |
| GILEAD SCIENCES, INC. | Treasurer | 2014-08-31 |
| LENZ THERAPEUTICS, INC. | Director/Board Member | - |
Training of Smital Shah
| Virginia Polytechnic Institute & State University | Graduate Degree |
| University of Mumbai | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Smital Shah
